Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2022-11-01
2023-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of COVID-19 Pandemic on Cancer Care
NCT04382495
The Effect of Self-Management Program Based on the Individual and Family Self-management Theory on Cancer Patients
NCT04822220
Patients Satisfaction With the Outcomes of Expensive Cytotoxic Agents
NCT02649725
Nurse-led Follow-up Care for Head and Neck Cancer Patients
NCT01167179
Online Survey: Oncologists' Thoughts Regarding Their Patients
NCT05437354
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims at describing the situation in our Arab countries and reflecting the pathway \& logistics of referring cancer patients to MDT \& the impact of that on the patients' management \& outcome, in addition to exploring the challenges that face effective implementation of MDT clinics, so that it can lead the improvement in oncology manangement
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Healthcare workers/Physicians involved in cancer diagnosis \& management in the Arab countries should respond to a survey
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Physicians who are not working in the Arab counties.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Riham H. AbdelAziz
Clinical Oncology Lecturer and consultant
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Oncosurvey
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.